Author:
Agius Mark A.,Fairclough Robert H.
Reference36 articles.
1. Relevance of experimental models of myasthenia to human acquired myasthenia gravis;Richman;Neurological Disease and Therapy Series,1994
2. Genes at the junction: candidates for congenital myasthenic syndromes;Vincent;Trends Neurosci,1997
3. Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit;Milone;J Neurosci,1997
4. Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction;Gomez;J Neurosci,1997
5. Fairclough RH, Gudipati E, Lin MY, Twaddle GM, Richman DP, Burkwall DA, Josephs R: A role α(187–199) in the conversion of agonist binding energy to the opening of the acetylcholine receptor ion channel. Ann NY Acad. In press.